Compliance and enforcement policy for health products (POL-0001): Compliance and enforcement actions and tools

On this page

Health Canada's first priority is to help mitigate risks to the health and safety of people in Canada, using actions and tools that are most appropriate for the situation. This may include recalls, stopping sale, seizing products and communicating risks or other information to the public. An inspector may use these actions and tools individually or in combination.

If a regulated party does not comply with the Act or its regulations, Health Canada considers various decision factors in alignment with the Health Canada Compliance and Enforcement Policy Framework to inform our choice of actions. Health Canada will choose a compliance and enforcement response proportionate to the identified health and safety risk. Sometimes, the seriousness of the risk warrants an immediate enforcement measure such as a licence suspension or cancellation, an application for an injunction or a referral to Public Prosecution Service of Canada for prosecution. Other times, based on the level or risk, the regulated party may be provided with an opportunity to come into compliance. Depending on the issue, additional factors may be taken into consideration including the need for people in Canada to have continued access to medically necessary health products or other unique circumstances to determine the most appropriate action. If non-compliance persists, actions taken may graduate towards stronger compliance and enforcement actions. We will adapt the type of enforcement response to the situation when the risk changes or considerations related to risk management evolve.

Health Canada uses compliance and enforcement actions and tools that fall under three categories:

  1. compliance promotion
  2. compliance monitoring
  3. enforcement

Compliance promotion

Compliance promotion aims to minimize health and safety risks and non-compliance with the Act and its regulations. To this end, Health Canada undertakes several activities to promote compliance and reduce risks to the public:

Compliance monitoring

Health Canada carries out compliance monitoring activities to verify compliance with the Act and its regulations, gather information on potential issues and identify risks posed by health products or activities. In particular, Health Canada:

The frequency, intensity and nature of compliance monitoring activities may vary according to the risks identified. Health Canada uses the information gathered through compliance monitoring to determine if further regulatory action is required.

Enforcement

Enforcement responses

Health Canada may take enforcement measures where there is a failure to meet the applicable requirements under the Act or regulations, whether unintentional or intentional. We have a number of enforcement options to address risk, compel or induce compliance and prevent future non-compliance. The type of enforcement action and level of intervention may differ based on the type of health product and the severity of the risk. We choose the most appropriate enforcement response based on the specifics of each case and in alignment with the Health Canada Compliance and Enforcement Policy Framework. Examples of enforcement actions include:

Injunction, Section 21.5 (1)

If, on the application of the Minister, it appears to a court of competent jurisdiction that a person has done, is about to do or is likely to do anything that constitutes or is directed toward the commission of an offence under this Act in respect of a therapeutic product, the court may issue an injunction ordering the person, who is to be named in the application, to

  • a) refrain from doing anything that it appears to the court may constitute or be directed toward the commission of the offence; or
  • b) do anything that it appears to the court may prevent the commission of the offence.

Regulated parties who are subject to a regulatory action or a decision can expect Health Canada to adhere to procedural fairness principles and be provided with a reasonable opportunity to be heard.

Other types of enforcement responses

Every person who contravenes any provision of the Act or its regulations is guilty of an offence. Health Canada may conduct an investigation into potential offences under the Act or make a referral to law enforcement.

Investigation

When Health Canada conducts an investigation, the investigator will gather evidence to support a prosecution pursuant to the authorities in the Criminal Code of Canada, which could include issuing production orders and executing search warrants.

Priority will be given to contraventions by parties who demonstrate a disregard for the legislative and regulatory requirements, who have a history of contravening the Act or who are engaging in activities that could cause serious harm. Such activities could include unduly preventing verification of compliance with the Act and its regulations, conducting licensable activities without the required licence, intentional avoidance of the law or selling unapproved products.

Prosecution

Health Canada may refer the results of its investigation to the Public Prosecution Service of Canada recommending prosecution in relation to offences under the Act, its regulations and the Criminal Code of Canada where applicable.

A person who is guilty of a criminal offence related to therapeutic products may be liable for penalties set out in sections 31, 31.2 or 31.4 of the Act. These sections contain offence provisions that provide for a fine, a term of imprisonment, or both.

Sections 31 and 31.2 offences are strict liability offences. This means that the accused can raise a defence of due diligence demonstrating that reasonable steps were taken to satisfy the requirements of the Act.

Contravention of Act or regulations, Section 31

Subject to sections 31.1, 31.2 and 31.4, every person who contravenes any of the provisions of this Act or of the regulations, or fails to do anything the person was ordered to do by an inspector under section 25 or 27.2, is guilty of an offence and liable

  • a) on summary conviction for a first offence to a fine not exceeding five hundred dollars or to imprisonment for a term not exceeding three months or to both and, for a subsequent offence, to a fine not exceeding one thousand dollars or to imprisonment for a term not exceeding six months or to both; and
  • b) on conviction on indictment to a fine not exceeding five thousand dollars or to imprisonment for a term not exceeding three years or to both.

Offences relating to therapeutic products, Section 31.2 (1)

Subject to section 31.4, every person who contravenes any provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable

  • a) on conviction by indictment, to a fine not exceeding $5,000,000 or to imprisonment for a term not exceeding two years or to both; and
  • b) on summary conviction, for a first offence, to a fine not exceeding $250,000 or to imprisonment for a term not exceeding six months or to both and, for a subsequent offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both.

Offences: section 21.6 and serious risk, Section 31.4 (1)

A person who contravenes section 21.6, or who knowingly or recklessly causes a serious risk of injury to human health in contravening another provision of this Act or the regulations, as it relates to a therapeutic product, or an order made under any of sections 21.1 to 21.32 is guilty of an offence and liable

  • a) on conviction on indictment, to a fine the amount of which is at the discretion of the court or to imprisonment for a term not exceeding five years or to both; and
  • b) on summary conviction, for a first offence, to a fine not exceeding $500,000 or to imprisonment for a term not exceeding 18 months or to both and, for a subsequent offence, to a fine not exceeding $1,000,000 or to imprisonment for a term not exceeding two years or to both.

Page details

2026-09-15